QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|
| |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) | |
|
| |
(Address of principal executive offices) |
(Zip Code) |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
|
|
|
|
☒ |
Accelerated filer |
☐ | |||
Non-accelerated filer |
☐ |
Smaller reporting company |
| |||
Emerging growth company |
|
Class of Common Stock |
Outstanding at October 31, 2019 | |
Voting common stock, $.01 par value |
|
Page of Form 10-Q |
||||||
Part I. |
Financial Information |
|||||
Item 1. |
Financial Statements (Unaudited): |
|||||
2 |
||||||
3 |
||||||
4 |
||||||
5 |
||||||
6 |
||||||
7 |
||||||
Item 2. |
29 |
|||||
Item 3. |
45 |
|||||
Item 4. |
45 |
|||||
Part II. |
Other Information |
|||||
Item 1. |
45 |
|||||
Item 1A. |
46 |
|||||
Item 2. |
46 |
|||||
Item 6. |
47 |
|||||
48 |
Quarter |
Nine Months |
|||||||||||||||
2019 |
2018 |
2019 |
2018 |
|||||||||||||
Revenues |
$ |
|
$ | |
$ |
|
$ | |
||||||||
Salaries and benefits |
|
|
|
|
||||||||||||
Supplies |
|
|
|
|
||||||||||||
Other operating expenses |
|
|
|
|
||||||||||||
Equity in earnings of affiliates |
( |
) |
( |
) | ( |
) |
( |
) | ||||||||
Depreciation and amortization |
|
|
|
|
||||||||||||
Interest expense |
|
|
|
|
||||||||||||
Gains on sales of facilities |
— |
( |
) | ( |
) |
( |
) | |||||||||
Losses on retirement of debt |
|
|
|
|
||||||||||||
|
|
|
|
|||||||||||||
Income before income taxes |
|
|
|
|
||||||||||||
Provision for income taxes |
|
|
|
|
||||||||||||
Net income |
|
|
|
|
||||||||||||
Net income attributable to noncontrolling interests |
|
|
|
|
||||||||||||
Net income attributable to HCA Healthcare, Inc. |
$ |
|
$ | |
$ |
|
$ | |
||||||||
Per share data: |
||||||||||||||||
Basic earnings |
$ |
|
$ | |
$ |
|
$ | |
||||||||
Diluted earnings |
$ |
|
$ | |
$ |
|
$ | |
||||||||
Shares used in earnings per share calculations (in millions): |
||||||||||||||||
Basic |
|
|
|
|
||||||||||||
Diluted |
|
|
|
|
Quarter |
Nine Months |
|||||||||||||||
2019 |
2018 |
2019 |
2018 |
|||||||||||||
Net income |
$ |
|
$ | |
$ |
|
$ | |
||||||||
Other comprehensive income (loss) before taxes: |
||||||||||||||||
Foreign currency translation |
( |
) |
( |
) | ( |
) |
( |
) | ||||||||
Unrealized gains (losses) on available-for-sale securities |
|
( |
) | |
( |
) | ||||||||||
Defined benefit plans |
|
— |
|
— |
||||||||||||
Pension costs included in salaries and benefits |
|
|
|
|
||||||||||||
|
|
|
|
|||||||||||||
Change in fair value of derivative financial instruments |
( |
) |
|
( |
) |
|
||||||||||
Interest benefits included in interest expense |
( |
) |
( |
) | ( |
) |
( |
) | ||||||||
( |
) |
|
( |
) |
|
|||||||||||
Other comprehensive (loss) income before taxes |
( |
) |
( |
) | ( |
) |
|
|||||||||
Income taxes (benefits) related to other comprehensive income items |
( |
) |
|
( |
) |
|
||||||||||
Other comprehensive (loss) income |
( |
) |
( |
) | ( |
) |
|
|||||||||
Comprehensive income |
|
|
|
|
||||||||||||
Comprehensive income attributable to noncontrolling interests |
|
|
|
|
||||||||||||
Comprehensive income attributable to HCA Healthcare, Inc. |
$ |
|
$ | |
$ |
|
$ | |
||||||||
September 30, 2019 |
December 31, 2018 |
|||||||
ASSETS |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ |
|
$ | |
||||
Accounts receivable |
|
|
||||||
Inventories |
|
|
||||||
Other |
|
|
||||||
|
|
|||||||
Property and equipment, at cost |
|
|
||||||
Accumulated depreciation |
( |
) |
( |
) | ||||
|
|
|||||||
Investments of insurance subsidiaries |
|
|
||||||
Investments in and advances to affiliates |
|
|
||||||
Goodwill and other intangible assets |
|
|
||||||
Right-of-use operating lease assets |
|
— |
||||||
Other |
|
|
||||||
$ |
|
$ | |
|||||
LIABILITIES AND STOCKHOLDERS’ DEFICIT |
||||||||
Current liabilities: |
||||||||
Accounts payable |
$ |
|
$ | |
||||
Accrued salaries |
|
|
||||||
Other accrued expenses |
|
|
||||||
Long-term debt due within one year |
|
|
||||||
|
|
|||||||
Long-term debt, less debt issuance costs and discounts of $ |
|
|
||||||
Professional liability risks |
|
|
||||||
Right-of-use operating lease obligations |
|
— |
||||||
Income taxes and other liabilities |
|
|
||||||
Stockholders’ deficit: |
||||||||
Common stock $ |
|
|
||||||
Accumulated other comprehensive loss |
( |
) |
( |
) | ||||
Retained deficit |
( |
) |
( |
) | ||||
Stockholders’ deficit attributable to HCA Healthcare, Inc. |
( |
) |
( |
) | ||||
Noncontrolling interests |
|
|
||||||
( |
) |
( |
) | |||||
$ |
|
$ | |
|||||
Equity (Deficit) Attributable to HCA Healthcare, Inc. |
Equity Attributable to Noncontrolling Interests |
Total |
||||||||||||||||||||||||||
Common Stock |
Capital in Excess of Par Value |
Accumulated Other Comprehensive Loss |
Retained Deficit |
|||||||||||||||||||||||||
Shares (in millions) |
Par Value |
|||||||||||||||||||||||||||
Balances, December 31, 2017 |
|
$ | |
$ | — |
$ | ( |
) | $ | ( |
) | $ | |
$ | ( |
) | ||||||||||||
Comprehensive income |
|
|
|
|
||||||||||||||||||||||||
Repurchase of common stock |
( |
) | |
( |
) | ( |
) | |||||||||||||||||||||
Share-based benefit plans |
|
( |
) | ( |
) | |||||||||||||||||||||||
Cash dividends declared ($ |
( |
) | ( |
) | ||||||||||||||||||||||||
Distributions |
( |
) | ( |
) | ||||||||||||||||||||||||
Other |
( |
) | ( |
) | ||||||||||||||||||||||||
Balances, March 31, 2018 |
|
|
— |
( |
) | ( |
) | |
( |
) | ||||||||||||||||||
Comprehensive income |
( |
) | |
|
|
|||||||||||||||||||||||
Repurchase of common stock |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||
Share-based benefit plans |
|
|
|
|||||||||||||||||||||||||
Cash dividends declared ($ |
( |
) | ( |
) | ||||||||||||||||||||||||
Distributions |
( |
) | ( |
) | ||||||||||||||||||||||||
Other |
( |
) | |
( |
) | |||||||||||||||||||||||
Balances, June 30, 2018 |
|
|
— |
( |
) | ( |
) | |
( |
) | ||||||||||||||||||
Comprehensive income |
( |
) | |
|
|
|||||||||||||||||||||||
Repurchase of common stock |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||
Share-based benefit plans |
|
|
|
|||||||||||||||||||||||||
Cash dividends declared ($ |
( |
) | ( |
) | ||||||||||||||||||||||||
Distributions |
( |
) | ( |
) | ||||||||||||||||||||||||
Other |
|
|
|
|||||||||||||||||||||||||
Balances, September 30, 2018 |
|
|
— |
( |
) | ( |
) | |
( |
) | ||||||||||||||||||
Comprehensive income |
( |
) | |
|
|
|||||||||||||||||||||||
Repurchase of common stock |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||
Share-based benefit plans |
|
|
|
|||||||||||||||||||||||||
Cash dividends declared ($ |
( |
) | ( |
) | ||||||||||||||||||||||||
Distributions |
( |
) | ( |
) | ||||||||||||||||||||||||
Other |
( |
) | ( |
) | |
|
|
|||||||||||||||||||||
Balances, December 31, 2018 |
|
|
— |
( |
) | ( |
) | |
( |
) | ||||||||||||||||||
Comprehensive income |
|
|
|
|
||||||||||||||||||||||||
Repurchase of common stock |
( |
) | |
( |
) | ( |
) | |||||||||||||||||||||
Share-based benefit plans |
|
( |
) | ( |
) | |||||||||||||||||||||||
Cash dividends declared ($ |
( |
) | ( |
) | ||||||||||||||||||||||||
Distributions |
( |
) | ( |
) | ||||||||||||||||||||||||
Other |
( |
) | |
|
||||||||||||||||||||||||
Balances, March 31, 2019 |
|
|
— |
( |
) | ( |
) | |
( |
) | ||||||||||||||||||
Comprehensive income |
( |
) | |
|
|
|||||||||||||||||||||||
Repurchase of common stock |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||
Share-based benefit plans |
|
|
|
|||||||||||||||||||||||||
Cash dividends declared ($ |
( |
) | ( |
) | ||||||||||||||||||||||||
Distributions |
( |
) | ( |
) | ||||||||||||||||||||||||
Other |
( |
) | ( |
) | ||||||||||||||||||||||||
Balances, June 30, 2019 |
|
|
— |
( |
) | ( |
) | |
( |
) | ||||||||||||||||||
Comprehensive income |
( |
) |
|
|
|
|||||||||||||||||||||||
Repurchase of common stock |
( |
) |
( |
) |
( |
) |
( |
) | ||||||||||||||||||||
Share-based benefit plans |
|
|
|
|||||||||||||||||||||||||
Cash dividends declared ($ |
( |
) |
( |
) | ||||||||||||||||||||||||
Distributions |
( |
) |
( |
) | ||||||||||||||||||||||||
Other |
|
( |
) |
( |
) | |||||||||||||||||||||||
Balances, September 30, 2019 |
|
$ |
|
$ |
— |
$ |
( |
) |
$ |
( |
) |
$ |
|
$ |
( |
) | ||||||||||||
2019 |
2018 |
|||||||
Cash flows from operating activities: |
||||||||
Net income |
$ |
|
$ | |
||||
Adjustments to reconcile net income to net cash provided by operating activities: |
||||||||
Increase (decrease) in cash from operating assets and liabilities: |
||||||||
Accounts receivable |
( |
) |
( |
) | ||||
Inventories and other assets |
( |
) |
( |
) | ||||
Accounts payable and accrued expenses |
( |
) |
|
|||||
Depreciation and amortization |
|
|
||||||
Income taxes |
|
— |
||||||
Gains on sales of facilities |
( |
) |
( |
) | ||||
Losses on retirement of debt |
|
|
||||||
Amortization of debt issuance costs and discounts |
|
|
||||||
Share-based compensation |
|
|
||||||
Other |
|